Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Aligos Therapeutics

< Previous 1 2 3 Next >
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Presents Positive Data at the EASL Congress 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Presents Positive Data at APASL 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces $105 Million Private Placement Financing
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics to Present at Investor Conferences in December
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
From Aligos Therapeutics
Via GlobeNewswire
Tickers ALGS
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.